Association between refill compliance to oral bisphosphonate treatment, incident fractures, and health care costs—an analysis using national health databases

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

Robert M. Neer, Claude D. Arnaud, José Zanchetta et al. · New England Journal of Medicine · 2001 · 4.6K citations

Medicine, Endocrinology, Bone Metabolism +16

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

Steven R. Cummings, Javier San Martín, Michael R. McClung et al. · New England Journal of Medicine · 2009 · 3.4K citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>

Bruce Ettinger · JAMA · 1999 · 3.4K citations

Medicine, Pharmacology, Pharmacotherapy +17

Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis

Joyce A. Cramer, Mayur M. Amonkar, Ansgar Hebborn et al. · Current Medical Research and Opinion · 2005 · 392 citations

Pharmacy, Clinical Pharmacy, Pharmacotherapy +16

Assessment of compliance with osteoporosis treatment and its consequences in a managed care population

Krista F. Huybrechts, K. Jack Ishak, J. Jaime · Bone · 2005 · 351 citations

Medicine, Health Policy, Health Care Compliance +11